SCHEMBL6942392

SCHEMBL6942392

O=C(O)CNC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1cccc(NS(=O)(=O)c2ccc3ccccc3c2)c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.48
GGPS1 O95749 1/20 0.47
CA2 P00918 1/20 0.44
GPR27 Q9NS67 1/20 0.44
KAT6A Q92794 1/20 0.43
SLC16A3 O15427 1/20 0.43
PLAT P00750 1/20 0.42
CAPN1 P07384 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PLAU P00749 1/20 0.42
PLG P00747 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
F2 P00734 2/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6944325 1.00 AKR1C3 (0.48) AKR1C3GGPS1CA2GPR27KAT6A
SCHEMBL7313713 0.87 CAPN1 (0.53) AKR1C3GGPS1CA2GPR27KAT6A
SCHEMBL6942097 0.87 CAPN1 (0.53) AKR1C3GGPS1CA2GPR27KAT6A
SCHEMBL7695396 0.84 AKR1C3 (0.48) AKR1C3GGPS1CA2GPR27KAT6A
SCHEMBL6947064 0.83 CTSD (0.48) AKR1C3GGPS1GPR27KAT6ASLC16A3
SCHEMBL7692550 0.83 AKR1C3 (0.51) AKR1C3GGPS1CA2GPR27KAT6A
SCHEMBL7694179 0.82 AKR1C3 (0.48) AKR1C3GGPS1CA2GPR27KAT6A
SCHEMBL7791335 0.81 AKR1C3 (0.54) AKR1C3GGPS1GPR27KAT6ASLC16A3
SCHEMBL7791333 0.81 AKR1C3 (0.54) AKR1C3GGPS1GPR27KAT6ASLC16A3
SCHEMBL7782218 0.80 AKR1C3 (0.53) AKR1C3GGPS1GPR27KAT6ASLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944582-B1 KETOBENZAMIDES AS CALPAIN INHIBITORS ABBOTT GMBH & CO KG (DE) 2003-07-02 EP disclosed
US-6103720-A ENZYME INHIBITORS; ANTIICHEMIC AND -TUMOR AGENTS; STROKES; ALZEIMER'S DISEASE BASF AKTIENGESELLSCHAFT (DE) 2000-08-15 US disclosed
EP-0944582-A1 KETOBENZAMIDES AS CALPAIN INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-09-29 EP disclosed
WO-1998025883-A1 KETOBENZAMIDES AS CALPAIN INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1998-06-18 WO disclosed